INOZYME PHARMA INC. - COMMON STOCK

Inozyme Pharma Announces Publication of Comprehensive ENPP1 Variant Database

31 10 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 9 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates

15 8 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures

26 7 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Subjects with ABCC6 Deficiency (pseudoxanthoma elasticum or PXE)

19 7 2022 16:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Announces Partnership with Rady Children’s Institute for Genomic Medicine to Advance Newborn Screening for Genetic Diseases

16 6 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Appoints Kurt Gunter, M.D., as Chief Medical Officer

07 6 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma to Present at the 2022 Jefferies Healthcare Conference

01 6 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Reports First Quarter 2022 Financial Results and Provides Business Highlights

10 5 2022 07:30:01 提供 Nasdaq GlobeNewswire

Inozyme Pharma to Present at Upcoming Investor Conferences

03 5 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market

14 4 2022 08:16:50 提供 Nasdaq GlobeNewswire

Inozyme Pharma Provides Update for Phase 1/2 Clinical Trials in ABCC6 Deficiency and ENPP1 Deficiency

12 4 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference

06 4 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency

04 4 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights

15 3 2022 17:24:24 提供 Nasdaq GlobeNewswire

Inozyme Pharma Strengthens Management Team with Two Executive Appointments

08 3 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma to Present at Cowen 42nd Annual Health Care Conference

01 3 2022 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Announces Dosing of First Patient in First-in-Human Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency

15 11 2021 07:30:01 提供 Nasdaq GlobeNewswire

Inozyme Pharma to Present at Upcoming Investor Conferences

11 11 2021 07:30:00 提供 Nasdaq GlobeNewswire

Inozyme Pharma Reports Third Quarter 2021 Financial Results and Provides Business Highlights

09 11 2021 16:05:03 提供 Nasdaq GlobeNewswire